Abstract: A display apparatus according to a concept of the disclosure includes: a display panel displaying an image in a front direction; a middle mold causing the display panel to be rested at a first position; and a chassis coupled with the middle mold in the front direction of the display panel, wherein the middle mold includes a restricting rib for restricting the display panel from departing from the first position and restricting the display panel from moving in a side direction, and the chassis includes a pressing rib being in an inclined shape and pressing the display panel toward the first position when the chassis is coupled with the middle mold in the state in which the display panel departs from the first position.

Abstract: A switching regulator including a first converting stage and a second converting stage may be provided. The first converting stage may include a first output capacitor connected between a first output node and ground, the first converting stage configured to receive a first input voltage and provide an output voltage by adjusting a level of the output voltage based on a first dynamic voltage scaling (DVS) rate relating to a first load condition of a processing circuit. The second converting stage may include a second output capacitor connected between a second output node and the ground, the second converting stage configured to receive a second input voltage and provide the output voltage by adjusting the level of the output voltage based on a second DVS rate relating to a second load condition of the processing circuit, which is heavier than the first load condition of the processing circuit.

Abstract: The present invention relates to an anti-inflammatory composition, and more particularly to an anti-inflammatory composition containing, as an active ingredient, a compound represented by Formula 1 or a salt thereof, wherein the anti-inflammatory composition may inhibit inflammatory response even at an early stage by inhibiting the interaction between CD14 and LPS and blocking the expression of CD14 and the expression of TNF? and IL-1?, which are the key factors in inflammatory response, and may also regulate the expression of important factors, such as CCL2 (MCP-1), CCL7 (MCP-3), CXCL2, CHOP and NOX1, which are involved in inflammatory response.

Abstract: A display apparatus according to a concept of the disclosure includes: a display panel displaying an image in a front direction; a middle mold causing the display panel to be rested at a first position; and a chassis coupled with the middle mold in the front direction of the display panel, wherein the middle mold includes a restricting rib for restricting the display panel from departing from the first position and restricting the display panel from moving in a side direction, and the chassis includes a pressing rib being in an inclined shape and pressing the display panel toward the first position when the chassis is coupled with the middle mold in the state in which the display panel departs from the first position.

Abstract: A switching regulator including a first converting stage and a second converting stage may be provided. The first converting stage may include a first output capacitor connected between a first output node and ground, the first converting stage configured to receive a first input voltage and provide an output voltage by adjusting a level of the output voltage based on a first dynamic voltage scaling (DVS) rate relating to a first load condition of a processing circuit. The second converting stage may include a second output capacitor connected between a second output node and the ground, the second converting stage configured to receive a second input voltage and provide the output voltage by adjusting the level of the output voltage based on a second DVS rate relating to a second load condition of the processing circuit, which is heavier than the first load condition of the processing circuit.

Abstract: The present invention relates to an anti-inflammatory composition, and more particularly to an anti-inflammatory composition containing, as an active ingredient, a compound represented by Formula 1 or a salt thereof, wherein the anti-inflammatory composition may inhibit inflammatory response even at an early stage by inhibiting the interaction between CD14 and LPS and blocking the expression of CD14 and the expression of TNF? and IL-1?, which are the key factors in inflammatory response, and may also regulate the expression of important factors, such as CCL2 (MCP-1), CCL7 (MCP-3), CXCL2, CHOP and NOX1, which are involved in inflammatory response.

Abstract: A switching regulator including a first converting stage and a second converting stage may be provided. The first converting stage may include a first output capacitor connected between a first output node and ground, the first converting stage configured to receive a first input voltage and provide an output voltage by adjusting a level of the output voltage based on a first dynamic voltage scaling (DVS) rate relating to a first load condition of a processing circuit. The second converting stage may include a second output capacitor connected between a second output node and the ground, the second converting stage configured to receive a second input voltage and provide the output voltage by adjusting the level of the output voltage based on a second DVS rate relating to a second load condition of the processing circuit, which is heavier than the first load condition of the processing circuit.

Abstract: The present invention relates to a novel compound and a composition for the prevention, alleviation or treatment of fibrosis or non-alcoholic steatohepatitis, which contains the compound as an active ingredient, and more particularly to a novel compound of Formula 1, which has an excellent effect on the prevention, alleviation or treatment of fibrosis, and to a composition for the prevention, alleviation or treatment of fibrosis or non-alcoholic steatohepatitis, which contains the compound as an active ingredient. The novel compound can regulate the activation of EMT (epithelial-mesenchymal transition) by effectively regulating the expression of snail and vimentin which are regulators of EMT, and thus can effectively prevent, alleviate or treat fibrosis. Furthermore, the novel compound has very good pharmacokinetics. In addition, the novel compound of the present invention can effectively inhibit fibrosis of liver cells, and thus can also effectively alleviate or treat non-alcoholic steatohepatitis.

Abstract: A compound represented by the following Formula 1 or a pharmaceutically acceptable salt thereof: wherein R1 is a substituted or unsubstituted C1-5 linear or branched alkyl, a C5-6 cycloalkyl, a C5-6 cycloalkyl containing at least one heteroatom selected from among O and N, a substituted or unsubstituted C6-12 aryl, or a C5-6 heteroaryl containing at least one heteroatom selected from among O and N; R2 is hydrogen, ethyl, acetyl, acetoxy, carboxy, benzoyloxy or 3,4,5-trihydroxybenzoyloxy; and R3 to R5 are each independently hydrogen, hydroxyl, methyl, methoxy, acetoxy, carboxy or benzoyloxy.

Abstract: The present invention relates to a composition for the treatment of gout, comprising an Angelica gigas Nakai extract which inhibits xanthine oxidase to reduce uric acid in the blood or urine, thereby being effective in the treatment of gout. Further, the present invention relates to a composition for the prevention of inflammation in gout, comprising an Angelica gigas Nakai extract which has an inhibitory effect on the inflammation-inducing enzyme Cox-2. The Angelica gigas Nakai extract of the present invention is a liquid concentrate consisting of 98% by weight or more of decursin and decursinol angelate as main ingredients, and for administration to human, it is extracted with water and ethanol only as an extraction solvent. In addition, a purification method using a difference in temperature and solubility is used, in order to increase its purity.

Abstract: A side air bag for a motor vehicle capable of protecting not only the lower body but also the upper body of an occupant in case of the lateral collision of a motor vehicle is disclosed. The side air bag for a motor vehicle, includes an air cushion; and a inflator for supplying a gas to the air cushion, wherein the air cushion have an upper body protection area for protecting an upper body including a head and a flank of an occupant; a hip protection area connected to a lower end of the upper body protection area for protecting a hip of the occupant; and a leg protection area connected to the hip protection area with projected forwardly from the hip protection area for protecting the leg of the occupant.

Abstract: The present invention relates to expression vectors containing in vivo urea cycle enzyme gene; transformants thereof; and the use of transformants for protein overexpression. During the overexpression of protein, if the animal cell transformed with expression vectors of the present invention is used, amounts of ammonia accumulation within cell culture medium will decrease and cell growth rate will increase, thus, it is advantageous to be capable of obtaining desired protein in high yields.

Abstract: An air bag door for a passenger seat of an automobile for improving a coupling construction of an air bag door and a housing.

Abstract: A variable cover of a curtain airbag for a vehicle includes a plurality of bellows, which control the angle and the extending length of a circular or a polygonal shaved cover. The variable cover also includes a rupturing part, which guides the spreading direction of an airbag cushion via hooks or scoring. The combination of features provided by the variable cover is standardized to accommodate the roof side rail of different vehicles.

Abstract: The present invention relates to expression vectors containing in vivo urea cycle enzyme gene; transformants thereof; and the use of transformants for protein overexpression. During the overexpression of protein, if the animal cell transformed with expression vectors of the present invention is used, amounts of ammonia accumulation within cell culture medium will decrease and cell growth rate will increase, thus, it is advantageous to be capable of obtaining desired protein in high yields.

Abstract: A curtain air bag includes a diffuser having an opening that emits operation gas, placed at a predetermined area along an inner side of a roof rail, a first cushion divided into first and second areas that limits a front seat and a rear seat, a third area that forms a front area of the first area, and a fourth area placed between the first area and the second area. The curtain airbag further includes a plurality of cushion holders that fix the first cushion into the roof rail by coupling to the top of the first cushion, a first downwardly extended portion of the first cushion connected to a lower surface of the first area and providing a predetermined area to protect ribs of a passenger sitting in the front seat, a second downwardly extended portion of the first cushion connected to a lower part of the second area and providing a predetermined area to protect ribs of a passenger sitting in the rear seat.

Abstract: The present invention provides an air bag assembly for installing a housing equipped with an inflator in the crush pad of the passenger seat and exposing an air bag door, which includes an upper housing coupled to the upper surface of the housing and has a penetrated hole in the center of the lower surface and a plurality of fixed holes in both upright surfaces. The air bag also includes a retainer, whose refracted part is coupled to the inside of the side surface of the upper housing, which is separated at a predetermined interval as much as the width of the refracted part to make a space from the side surface, a locking part which is created as a form of wedge in the inserting part of the lower surface of an air bag door to be inserted into the fixed hole by being inserted into the upper housing and the space of the retainer.

Abstract: Disclosed is an airbag for a vehicle capable of minimizing gas leakage in an early stage through gas discharge holes in a housing when spreading an air cushion. In both sides opposite to a first housing, the gas discharge holes are formed for emitting gas. A retainer on whose upper surface is fixed the air cushion, and in whose both sides are formed a coupling having coupling holes corresponding to the gas discharge holes, is provided. This coupling part is coupled to the first housing through the coupling device. The gas discharge holes are made lengthwise to make it possible to move the retainer up and down. As a result, when reading the air cushion, some of the holes are opened by movement of the coupling part. Besides, the coupling holes reformed in the lower side of the coupling part, so when not spreading the air cushion, the gas discharge holes are kept closed by the coupling part.

Abstract: Disclosed is a structure for installing an air bag module on a steering wheel, capable of improving operation performance of the air bag module by maximizing space utilization of an interior of the steering wheel, and by minimizing interference between parts. A structure for installing an air bag module on a steering wheel includes: a main body consisting of a rim constituting an outer ring, a core constituting a center portion, a spoke connecting the rim with the core; an inflator mounted on the rim, one end of which is connected with a connector, and to the other end of which a nozzle for discharging a gas, is provided; an air bag for expanding, provided with the gas from the inflator; a cushion housing for receiving the air bag and is fixed to an upper plane of the core; and a pipe tube for sealing surroundings of the nozzle, and connecting the inflator with the housing.

Abstract: Disclosed is a variable cover of a curtain airbag for a vehicle, comprising a plurality of bellows, which can control the angle and length of the cover which has a circular or polygonal shape, and an exploding part, which guides the spreading direction by being exploded by an exploding pressure of an airbag cushion, by a hook or a scoring process. This can guide the standardization of a cover which can be applied to the roof side rail of different vehicles. Thereby, it contributes to reduce the manufacturing cost by preventing manufacturing the cover individually in accordance with the existing vehicles and enhance a worker's convenience by aiming at an uniformity of the working process.